Zhan J - Search Results

1

Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibody.

Kalim M, Ali H, Rehman AU, Lu Y, Zhan J. Kalim M, et al. Among authors: zhan j. Front Immunol. 2022 Oct 21;13:1012499. doi: 10.3389/fimmu.2022.1012499. eCollection 2022. Front Immunol. 2022. PMID: 36341340 Free PMC article.

2

Construction of high level prokaryotic expression and purification system of PD-L1 extracellular domain by using Escherichia coli host cell machinery.

Kalim M, Chen J, Wang S, Lin C, Ullah S, Liang K, Ding Q, Chen S, Zhan J. Kalim M, et al. Among authors: zhan j. Immunol Lett. 2017 Oct;190:34-41. doi: 10.1016/j.imlet.2017.06.004. Epub 2017 Jul 3. Immunol Lett. 2017. PMID: 28684274

3

Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates.

Kalim M, Chen J, Wang S, Lin C, Ullah S, Liang K, Ding Q, Chen S, Zhan J. Kalim M, et al. Among authors: zhan j. Drug Des Devel Ther. 2017 Aug 2;11:2265-2276. doi: 10.2147/DDDT.S135571. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28814834 Free PMC article. Review.

4

Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma.

Wang S, Kalim M, Liang K, Zhan J. Wang S, et al. Among authors: zhan j. Prep Biochem Biotechnol. 2018 May 28;48(5):435-445. doi: 10.1080/10826068.2018.1452258. Epub 2018 Apr 16. Prep Biochem Biotechnol. 2018. PMID: 29561231

5

Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapy.

Kalim M, Liang K, Khan MSI, Zhan J. Kalim M, et al. Among authors: zhan j. Cytotechnology. 2019 Jun;71(3):705-722. doi: 10.1007/s10616-019-00316-3. Epub 2019 May 16. Cytotechnology. 2019. PMID: 31098772 Free PMC article.

6

Engineered scPDL1-DM1 drug conjugate with improved in vitro analysis to target PD-L1 positive cancer cells and intracellular trafficking studies in cancer therapy.

Kalim M, Wang S, Liang K, Khan MSI, Zhan J. Kalim M, et al. Among authors: zhan j. Genet Mol Biol. 2020 Jan 17;42(4):e20180391. doi: 10.1590/1678-4685-GMB-2018-0391. eCollection 2020. Genet Mol Biol. 2020. PMID: 31967634 Free PMC article.

7

Programmed cell death ligand-1: A dynamic immune checkpoint in cancer therapy.

Kalim M, Iqbal Khan MS, Zhan J. Kalim M, et al. Among authors: zhan j. Chem Biol Drug Des. 2020 Jun;95(6):552-566. doi: 10.1111/cbdd.13677. Epub 2020 Mar 28. Chem Biol Drug Des. 2020. PMID: 32166894 Review.

8

Virulent Drexlervirial Bacteriophage MSK, Morphological and Genome Resemblance With Rtp Bacteriophage Inhibits the Multidrug-Resistant Bacteria.

Khan MSI, Gao X, Liang K, Mei S, Zhan J. Khan MSI, et al. Among authors: zhan j. Front Microbiol. 2021 Aug 24;12:706700. doi: 10.3389/fmicb.2021.706700. eCollection 2021. Front Microbiol. 2021. PMID: 34504479 Free PMC article.

9

[Development of antibody drugs targeting against HER2 for cancer therapy].

Tang Q, Ding Q, Lin L, Zhang ZZ, Dai Z, Zhan JB. Tang Q, et al. Yao Xue Xue Bao. 2012 Oct;47(10):1297-305. Yao Xue Xue Bao. 2012. PMID: 23289141 Review. Chinese.

10

[Development of therapeutic antibodies for gastric and colorectal cancers].

Zhao TT, Fan NN, Lin L, Din Q, Zhan JB. Zhao TT, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 May;41(3):345-52. doi: 10.3785/j.issn.1008-9292.2012.03.019. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 22723173 Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,684 results

Search Page

Filters